Company 1 identity field
Location
Denver, CO
SEC filing record 1 source field
Fiscal year end
30 June
AYTU BIOPHARMA, INC has filed 893 SEC EDGAR filings since 11 Jan 2007

SEC filing history

Showing 626-650 of 868 matching filings.

Per page
25
Current page
26
8-K File 000-53121

8-K

Filing date
11 May 2017
Reporting date
11 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53121

8-K

Filing date
09 May 2017
Reporting date
03 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-212100

424B3

Filing date
04 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-212100

EFFECT filing

Filing date
25 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-212100

POST-EFFECTIVE AMENDMENT NO. 1

Filing date
18 Apr 2017
Reporting date
Not listed
Next action
Verify source filing
424B3 File 333-213489

424B3

Filing date
18 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53121

FORM 8-K

Filing date
18 Apr 2017
Reporting date
14 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-213489

424B3

Filing date
12 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-213489

424B3

Filing date
12 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53121

FORM 8-K

Filing date
05 Apr 2017
Reporting date
31 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-213489

EFFECT filing

Filing date
04 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53121

FORM 8-K

Filing date
17 Mar 2017
Reporting date
13 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
08 Mar 2017
Reporting date
27 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2017
Reporting date
27 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2017
Reporting date
27 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2017
Reporting date
27 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .